Apart from the overexpression of ENPEP, CK2-α, CCNJ, and MEGF9 in certain breast cancer patients, the potential oncogenic roles of these proteins is supported by the fact that their downregulation causes significant inhibition of cell proliferation. The gene discussed is CCNJ; the disease is breast carcinoma.